Cargando…
Opioids for non-operable osteoarthritis and soft-tissue rheumatism
Reviews of oral opioid trials have shown that many side-effects need to be considered when treating patients with non-operable osteoarthritis and soft-tissue problems. European and American guidelines recommend their use with or without paracetamol. The controversy surrounding the use of non-steroid...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257452/ https://www.ncbi.nlm.nih.gov/pubmed/16207348 http://dx.doi.org/10.1186/ar1817 |
_version_ | 1782125809955241984 |
---|---|
author | Dickson, David John |
author_facet | Dickson, David John |
author_sort | Dickson, David John |
collection | PubMed |
description | Reviews of oral opioid trials have shown that many side-effects need to be considered when treating patients with non-operable osteoarthritis and soft-tissue problems. European and American guidelines recommend their use with or without paracetamol. The controversy surrounding the use of non-steroidal anti-inflammatory drugs/cyclo-oxygenase-2 inhibitors is limiting physician and patient choices. There is a great need for alternative medication or ways of using current compounds. |
format | Text |
id | pubmed-1257452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-12574522005-10-19 Opioids for non-operable osteoarthritis and soft-tissue rheumatism Dickson, David John Arthritis Res Ther Commentary Reviews of oral opioid trials have shown that many side-effects need to be considered when treating patients with non-operable osteoarthritis and soft-tissue problems. European and American guidelines recommend their use with or without paracetamol. The controversy surrounding the use of non-steroidal anti-inflammatory drugs/cyclo-oxygenase-2 inhibitors is limiting physician and patient choices. There is a great need for alternative medication or ways of using current compounds. BioMed Central 2005 2005-08-25 /pmc/articles/PMC1257452/ /pubmed/16207348 http://dx.doi.org/10.1186/ar1817 Text en Copyright © 2005 BioMed Central Ltd |
spellingShingle | Commentary Dickson, David John Opioids for non-operable osteoarthritis and soft-tissue rheumatism |
title | Opioids for non-operable osteoarthritis and soft-tissue rheumatism |
title_full | Opioids for non-operable osteoarthritis and soft-tissue rheumatism |
title_fullStr | Opioids for non-operable osteoarthritis and soft-tissue rheumatism |
title_full_unstemmed | Opioids for non-operable osteoarthritis and soft-tissue rheumatism |
title_short | Opioids for non-operable osteoarthritis and soft-tissue rheumatism |
title_sort | opioids for non-operable osteoarthritis and soft-tissue rheumatism |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257452/ https://www.ncbi.nlm.nih.gov/pubmed/16207348 http://dx.doi.org/10.1186/ar1817 |
work_keys_str_mv | AT dicksondavidjohn opioidsfornonoperableosteoarthritisandsofttissuerheumatism |